IP Verse

Inhibition Of Hsd17b13 In The Treatment Of Liver Disease In Patients Expressing The Pnpla3 I148m Variation - EP3695012

PATENT ANALYSIS

Patent Details

Grant Date
Mar 8, 2023
Company
REGENERON PHARMACEUTICALS, INC.
Oppositions

STRAWMAN LIMITED

More patents of Regeneron Pharmaceuticals, Inc.

EP4011915

EP2967015

EP3384049

Want to monitor this patent?

Feel free to send us a message here and we will get back to you